» Articles » PMID: 20534153

Attention-deficit Hyperactivity Disorder (ADHD) and Glial Integrity: an Exploration of Associations of Cytokines and Kynurenine Metabolites with Symptoms and Attention

Overview
Publisher Biomed Central
Date 2010 Jun 11
PMID 20534153
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In contrast to studies of depression and psychosis, the first part of this study showed no major differences in serum levels of cytokines and tryptophan metabolites between healthy children and those with attention-deficit/hyperactivity disorder of the combined type (ADHD). Yet, small decreases of potentially toxic kynurenine metabolites and increases of cytokines were evident in subgroups. Therefore we examined predictions of biochemical associations with the major symptom clusters, measures of attention and response variability.

Methods: We explored systematically associations of 8 cytokines (indicators of pro/anti-inflammatory function) and 5 tryptophan metabolites with symptom ratings (e.g. anxiety, opposition, inattention) and continuous performance test (CPT) measures (e.g. movement, response time (RT), variability) in 35 ADHD (14 on medication) and 21 control children. Predictions from linear regressions (controlled by the false discovery rate) confirmed or disconfirmed partial correlations accounting for age, body mass and socio-economic status.

Results: (1) Total symptom ratings were associated with increases of the interleukins IL-16 and IL-13, where relations of IL-16 (along with decreased S100B) with hyperactivity, and IL-13 with inattention were notable. Opposition ratings were predicted by increased IL-2 in ADHD and IL-6 in control children. (2) In the CPT, IL-16 related to motor measures and errors of commission, while IL-13 was associated with errors of omission. Increased RT variability related to lower TNF-alpha, but to higher IFN-gamma levels. (3) Tryptophan metabolites were not significantly related to symptoms. But increased tryptophan predicted errors of omission, its breakdown predicted errors of commission and kynurenine levels related to faster RTs.

Conclusions: Many associations were found across diagnostic groups even though they were more marked in one group. This confirms the quantitative trait nature of these features. Conceptually the relationships of the pro- and antiinflammatory cytokines distinguished between behaviours associated more with cognitive or more with motor control respectively. Further study should extend the number of immunological and metabolic markers to confirm or refute the trends reported here and examine their stability from childhood to adolescence in a longitudinal design.

Citing Articles

Alterations in Striatal Architecture and Biochemical Markers' Levels During Postnatal Development in the Rat Model of an Attention Deficit/Hyperactivity Disorder (ADHD).

Bogdanska-Chomczyk E, Wojtacha P, Tsai M, Huang A, Kozlowska A Int J Mol Sci. 2025; 25(24.

PMID: 39769412 PMC: 11680085. DOI: 10.3390/ijms252413652.


Age-related changes in the architecture and biochemical markers levels in motor-related cortical areas of SHR rats-an ADHD animal model.

Bogdanska-Chomczyk E, Wojtacha P, Tsai M, Huang A, Kozlowska A Front Mol Neurosci. 2024; 17:1414457.

PMID: 39246601 PMC: 11378348. DOI: 10.3389/fnmol.2024.1414457.


Transcranial photobiomodulation for neurodevelopmental disorders: a narrative review.

Coelho D, Renet C, Lopez-Rodriguez S, Cassano P, Vieira W Photochem Photobiol Sci. 2024; 23(8):1609-1623.

PMID: 39009808 DOI: 10.1007/s43630-024-00613-7.


Male-biased vulnerability of mouse brain tryptophan/kynurenine and glutamate systems to adolescent exposures to concentrated ambient ultrafine particle air pollution.

Cory-Slechta D, Marvin E, Welle K, Goeke C, Chalupa D, Oberdorster G Neurotoxicology. 2024; 104:20-35.

PMID: 39002649 PMC: 11377152. DOI: 10.1016/j.neuro.2024.07.004.


Metabolomic Markers in Attention-Deficit/Hyperactivity Disorder (ADHD) among Children and Adolescents-A Systematic Review.

Predescu E, Vaidean T, Rapciuc A, Sipos R Int J Mol Sci. 2024; 25(8).

PMID: 38673970 PMC: 11050195. DOI: 10.3390/ijms25084385.


References
1.
Chiarugi A, Calvani M, Meli E, Traggiai E, Moroni F . Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages. J Neuroimmunol. 2001; 120(1-2):190-8. DOI: 10.1016/s0165-5728(01)00418-0. View

2.
Barry S, Clarke G, Scully P, Dinan T . Kynurenine pathway in psychosis: evidence of increased tryptophan degradation. J Psychopharmacol. 2008; 23(3):287-94. DOI: 10.1177/0269881108089583. View

3.
Leipnitz G, Schumacher C, Dalcin K, Scussiato K, Solano A, Funchal C . In vitro evidence for an antioxidant role of 3-hydroxykynurenine and 3-hydroxyanthranilic acid in the brain. Neurochem Int. 2006; 50(1):83-94. DOI: 10.1016/j.neuint.2006.04.017. View

4.
Lasky-Su J, Neale B, Franke B, Anney R, Zhou K, Maller J . Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet B Neuropsychiatr Genet. 2008; 147B(8):1345-54. DOI: 10.1002/ajmg.b.30867. View

5.
Steiner J, Bernstein H, Bielau H, Farkas N, Winter J, Dobrowolny H . S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study. J Psychiatr Res. 2007; 42(10):868-76. DOI: 10.1016/j.jpsychires.2007.10.001. View